SCHEMBL4061175

SCHEMBL4061175

CC(C)COC(=O)NC1CCNC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.43
KCNH2 Q12809 1/20 0.40
DRD2 P14416 2/20 0.39
EPHX1 P07099 4/20 0.38
KDM1A O60341 1/20 0.38
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 1/20 0.35
OPRK1 P41145 1/20 0.35
GNAI3 P08754 1/20 0.34
GNAO1 P09471 1/20 0.34
GNAI1 P63096 1/20 0.34
HTR1A P08908 1/20 0.34
HTR2A P28223 1/20 0.34
BTK Q06187 1/20 0.34
RAB9A P51151 1/20 0.33
DRD4 P21917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL966144 0.91 MAPK1 (0.44) HSD11B1DRD2EPHX1SMN1; SMN2MAPK1
SCHEMBL643094 0.90 EPHX1 (0.48) HSD11B1DRD2EPHX1POLBSMN1; SMN2
SCHEMBL3835430 0.87 HSD11B1 (0.43) HSD11B1DRD2EPHX1SMN1; SMN2MAPK1
SCHEMBL14224187 0.82 KCNH2 (0.47) HSD11B1KCNH2DRD2EPHX1KDM1A
SCHEMBL2426353 0.82 KCNH2 (0.47) HSD11B1KCNH2DRD2EPHX1KDM1A
SCHEMBL14224181 0.82 KCNH2 (0.47) HSD11B1KCNH2DRD2EPHX1KDM1A
SCHEMBL14919674 0.81 DRD2 (0.50) HSD11B1DRD2EPHX1SMN1; SMN2MAPK1
Hydrochloric Acid SCHEMBL17560365 0.81 KCNH2 (0.46) HSD11B1KCNH2DRD2EPHX1KDM1A
Hydrochloric Acid SCHEMBL28954175 0.81 KCNH2 (0.46) HSD11B1KCNH2DRD2EPHX1KDM1A
Hydrochloric Acid SCHEMBL17560364 0.81 KCNH2 (0.46) HSD11B1KCNH2DRD2EPHX1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0391169-A2 Enantiomeric pure 7-(3-amino-1-pyrrolidinyl)-chinolon-and-naphthyridon carboxylic acids BAYER AG (DE) 1990-10-10 EP claimed
EP-1653961-A4 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORP (US) 2009-04-01 EP disclosed
EP-1976498-A2 CHEMICAL COMPOUNDS SmithKline Beecham Corporation (US) 2008-10-08 EP disclosed
WO-2007127505-A2 USE OF SULFONAMIDE DERIVATIVES IN THE TREATMENT OF DISORDERS OF THE METABOLISM AND THE NERVOUS SYSTEM SMITHKLINE BEECHAM CORPORATION (US) 2007-11-08 WO disclosed
EP-1653961-A1 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2006-05-10 EP disclosed
WO-2005011700-A1 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2005-02-10 WO disclosed
EP-0391169-A2 Enantiomeric pure 7-(3-amino-1-pyrrolidinyl)-chinolon-and-naphthyridon carboxylic acids BAYER AG (DE) 1990-10-10 EP disclosed